Skip to Content
  • Previous Rank
    -
  • Revenue 3 Yr Annual Growth Rate
    32%
  • Revenue 3 Yr Growth Rank
    44
  • EPS 3 Yr Annual Growth Rate
    25%
  • EPS 3 Yr Growth Rank
    87
  • Total Return 3 Yr Annual Rate
    39%
  • Total Return 3 Yr Rank
    25

Company Information

Revenue and net income for the four quarters ended on or before April 30, 2019. Total return for the period ended June 28, 2019.
Industry
Medical Products & Equipment
Sector
Health Care
Current Streak-
Years on List1
CEO
Adam Elsesser
Websitehttps://www.penumbrainc.com
Country
U.S.
Headquarters
Alameda, Calif.
Ticker
PEN

Revenue, Net Income

Revenue past four quarters ($M)$471
Net Income past four quarters ($M)$12
Market Value as of June 28, 2019 ($M)$5,558

Growth Rates and Ranks

Revenue 3 Yr Growth Rank44
Revenue 3 Yr Annual Growth Rate32%
EPS 3 Yr Growth Rank87
EPS 3 Yr Annual Growth Rate25%
Total Return 3 Yr Rank25
Total Return 3 Yr Annual Rate39%
Beat S&P 500 3 Yr Return (14.2%)
yes